Profilo
Sanjeev Ahuja worked as Chief Medical Officer at Celtaxsys, Inc. and Mayne Pharma Group Ltd.
He also worked as Chief Medical Officer at Fresh Tracks Therapeutics, Inc. from 2019 to 2020.
Ahuja holds an MBA from the University of Cincinnati and a doctorate from Armed Forces Medical College.
Precedenti posizioni note di Sanjeev Ahuja
| Società | Posizione | Fine |
|---|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 29/02/2020 |
| MAYNE PHARMA GROUP LIMITED | Direttore Tecnico/Scientifico/R&S | - |
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Sanjeev Ahuja
| University of Cincinnati (Ohio) | Masters Business Admin |
| Armed Forces Medical College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MAYNE PHARMA GROUP LIMITED | Health Technology |
| FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
- Borsa valori
- Insiders
- Sanjeev Ahuja
